TY  - JOUR
AU  - Reiter, Russel J
AU  - Rosales-Corral, Sergio A
AU  - Tan, Dun-Xian
AU  - Acuna-Castroviejo, Dario
AU  - Qin, Lilan
AU  - Yang, Shun-Fa
AU  - Xu, Kexin
PY  - 2017
DO  - 10.3390/ijms18040843
UR  - http://hdl.handle.net/10668/11109
T2  - International journal of molecular sciences
AB  - There is highly credible evidence that melatonin mitigates cancer at the initiation, progression and metastasis phases. In many cases, the molecular mechanisms underpinning these inhibitory actions have been proposed. What is rather perplexing,...
LA  - en
PB  - MDPI AG
KW  - angiogenesis
KW  - antioxidant
KW  - apoptosis
KW  - breast
KW  - chemotherapy
KW  - free radicals
KW  - invasion
KW  - ionizing radiation
KW  - melatonin receptors
KW  - molecular mechanisms
KW  - prostate
KW  - Animals
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cell Transformation, Neoplastic
KW  - DNA Damage
KW  - Disease Progression
KW  - Drug Resistance, Neoplasm
KW  - Genomic Instability
KW  - Humans
KW  - Melatonin
KW  - Neoplasm Metastasis
KW  - Neoplasms
KW  - Radiation-Protective Agents
KW  - Treatment Outcome
TI  - Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
TY  - research article
VL  - 18
ER  -